(267 days)
K931595B
Not Found
No
The description focuses on the physical and chemical processes of reverse osmosis and water treatment, with automated functions based on pre-set intervals and sensor readings (like conductivity and flow). There is no mention of learning, adaptation, or complex pattern recognition characteristic of AI/ML.
No
The device produces water for hemodialysis, which is used in a therapeutic procedure, but the device itself is not directly therapeutic. It's a water purification system, not a device that treats a patient's condition.
No
The device is designed to produce high-quality water for hemodialysis, focusing on purification and disinfection rather than diagnosing a medical condition.
No
The device description details a physical water treatment system utilizing reverse osmosis, pumps, valves, and other hardware components. It is not solely software.
Based on the provided text, the Gambro Central Water Treatment System CWP 100 – WRO H is not an In Vitro Diagnostic (IVD) device.
Here's why:
- Intended Use: The intended use is to produce water of adequate quality for hemodialysis. This is a process that supports a medical treatment (hemodialysis), but it does not involve testing samples taken from the human body (in vitro).
- Device Description: The description focuses on the physical process of water purification using reverse osmosis and heat disinfection. It describes the mechanical and operational aspects of the system for producing purified water.
- Lack of IVD Characteristics: The text does not mention any of the typical characteristics of an IVD device, such as:
- Analyzing biological samples (blood, urine, tissue, etc.)
- Detecting or measuring substances in biological samples
- Providing diagnostic information about a patient's health status
- Using reagents or assays for testing
The device is a water purification system used in a clinical setting (hemodialysis unit) to prepare water for a medical procedure. While the quality of the water is critical for the safety and effectiveness of hemodialysis, the system itself is not performing a diagnostic test on a patient sample.
N/A
Intended Use / Indications for Use
The Gambro Central Water Treatment System CWP 100 – WRO H is designed to produce water of adquate quality for hemodialysis, both chemically and microbiologically with an adequate flow, provided that the feed water complies with the existing standards for drinking water and has been properly pre-treated.
Product codes (comma separated list FDA assigned to the subject device)
78 FIP
Device Description
The Gambro Central Water Treatment System CWP 100 - WRO H is designed to produce water of adquate quality for hemodialysis, both chemically and microbiologically with an adequate flow, provided that the feed water complies with the existing standards for drinking water and has been properly pre-treated. The WRO or the base unit of the CWP system, operates under the principle of reverse osmosis (RO) which is the preferred method for the purificationof water for hemodialysis. This system removes at least 95% of the total dissolved salts (based on conductivity measurements) and more than 99% of the bacteria and endotoxins from the inlet water. The WRO H also include a heat disinfection unit for disinfection of the distribution system which utilizes hot water to minimize any form of microbial growth and biofilf formation. With this system, dialysis machines can be included in this heat disinfection cycle, provided that they have heat disinfection capability. This procedure is called integrated heat disinfection.
In order to ensure that the microbiological quality will be maintained, this system has:
- an automated disinfection procedure to keep the membrane surfaces clean and to . minimize bacterial growth;
- a hygenic design with smooth surfaces and a minimum of stagnant zones; .
- automatic flushing programs at preset intervals when the system is not in use ●
In addition, the WRO H has been designed to reduce water consumption by automatically regulating the pump speed to the actual demand of pure water.
After pretreatment (i.e. sediment filter, water softener, charcoal filter, etc.) the water enters an inlet tank (please refer to position 4 on the following diagram) via a solenoid valve (1). The inlet water tank (4) has a float valve (5) and an air gap to help isolate the flowpath from the municipal water system. The main pump (33) then creates a pressure of up to 20 bar that is required for the reverse osmosis process.
Pure water from the WRO unit is distributed directly to the distribution system in the hemodialysis unit via solenoid valves (48), (103), and (105). Excess pure water that has not been used in the hemodialysis unit is recirculated back to the inlet water tank (4) via solenoid valve (106).
In order to reduce water consumption, the speed of the pump is automatically adjusted so that the return flow of water is kept constant. Part of the reject water is recirculated back to the sucking side of the main pump via valve (71) to help minimize water consumption and to maintain a high flow velocity over the membrane surface. The rest of the reject water is, however, continuously sent to the drain via a needle valve (41).
The WRO unit utilizes a proportioning pump (45) and solution container (46) to proportion disinfectant during the disinfection cycle. The proportioning pump is disconnected from the flow path during normal operation.
The pure water line has a solenoid valve (36) for automatic flushing to drain at the start up, in conductivity alarm situations, every two hours, when the unit is in stand-by mode and at rinse during disinfection. The pure water line also has a solenoid valve arrangement to isolate the system from the distribution system during disinfection. The WRO unit has an overflow valve (64) on the pure water side to control pressure and to relieve pressure peaks.
Conductivity Monitoring
The conductivity of the inlet water and pure water are continuously monitored by two conductivity cells (32) and are presented on the display on the operator's panel.
Flow Monitoring
The following flow rates are monitored
- Inlet Water, Sensor Position: 3, Designation: F1
- Reject From the RO Unit, Sensor Position: 42, Designation: F2
- Return Pure Water from the Clinic, Sensor Position: 51, Designation: F4
These flow rates are used to calculate the following:
- Actual pure water consumption, . (F5=F1-F2)
- Outlet pure water flow, . (F6=F1-F2+F4)
All flow rates are presented on the operator's panel on request.
Heat Disinfection Unit
The heat disinfection unit consists of a tank (90) made of stainless steel and an electrical heater (91). The heater maintains the temperature of the pure water in the tank at either 60 ℃ (Low) or 90 ℃ (High). Heat disinfection of the pure water distribution system is initiated by the operator at the end of the dialysis day / session. A circulation pump (96) circulates hot water in the loop until the process is interrupted either manually by the operator, or at a preset time prior to the start of the next dialysis day / session. During the disinfection period, integrated heat disinfection with the dialysis machines can also be performed if the dialysis machines have a heat disinfection capability. The tank automatically refills with pure water from the WRO unit during the next operation. Heating of the water from 60 ℃ (Low) to 90 ℃ (High) takes approximately 2.5 hours if no circulation the loop takes place. During circulation periods the required time is longer because of heat losses and varies depending on the length and design of the system.
Heating Capacity
The heat disinfection unit is capable of maintaining 85 ℃ in a well insulated piping system with a maximum length of 150 meters.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Not Found
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Non-Clinical Tests:
In vitro performance testing was performed on the Gambro Central Water Treatment Systems to establish normal operating performance to include flow rates, rejection of dissolved salts, organic materials, bacteria, and pyrogen. Additional testing was performed to evaluate the safety of the materials having water contact at various temperatures. The results of these tests confirmed that the proposed device is substantially equivalent to the proposed device for these parameters.
Clinical Test Results:
Clinical testing was not performed
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.
K931595B
Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).
Not Found
§ 876.5665 Water purification system for hemodialysis.
(a)
Identification. A water purification system for hemodialysis is a device that is intended for use with a hemodialysis system and that is intended to remove organic and inorganic substances and microbial contaminants from water used to dilute dialysate concentrate to form dialysate. This generic type of device may include a water softener, sediment filter, carbon filter, and water distillation system.(b)
Classification. Class II (special controls). The device, when it is a water purification subsystem disinfectant, is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 876.9.
0
| K974899 p. 1/5 | |
|---|---|
| 510K Notification | |
| Gambro Central Water Treatment System CWP 100 – WRO H December 23rd, 1997 |
SEP 23 1998
| 510K(k) SUMMARY | |
|---|---|
| SUBMITTER: | Gambro Healthcare |
| 1185 Oak Street | |
| Lakewood, CO 80215 | |
| (303) 231-4436 | |
| DATE PREPARED: | Friday, December 26, 1997 |
| DEVICE NAME: | Gambro Central Water Treatment System |
| CWP 100 – WRO H | |
| CLASSIFICATION NAMES: | Water Purification System for Hemodialysis |
| PREDICATE DEVICE: | Osmonics Osmo 23 G Series Reverse Osmosis |
| Machines |
Device Description:
General Description
The Gambro Central Water Treatment System CWP 100 - WRO H is designed to produce water of adquate quality for hemodialysis, both chemically and microbiologically with an adequate flow, provided that the feed water complies with the existing standards for drinking water and has been properly pre-treated. The WRO or the base unit of the CWP system, operates under the principle of reverse osmosis (RO) which is the preferred method for the purificationof water for hemodialysis. This system removes at least 95% of the total dissolved salts (based on conductivity measurements) and more than 99% of the bacteria and endotoxins from the inlet water. The WRO H also include a heat disinfection unit for disinfection of the distribution system which utilizes hot water to minimize any form of microbial growth and biofilf formation. With this system, dialysis machines can be included in this heat disinfection cycle, provided that they have heat disinfection capability. This procedure is called integrated heat disinfection.
In order to ensure that the microbiological quality will be maintained, this system has:
- an automated disinfection procedure to keep the membrane surfaces clean and to . minimize bacterial growth;
- a hygenic design with smooth surfaces and a minimum of stagnant zones; .
- automatic flushing programs at preset intervals when the system is not in use ●
In addition, the WRO H has been designed to reduce water consumption by automatically regulating the pump speed to the actual demand of pure water.
After pretreatment (i.e. sediment filter, water softener, charcoal filter, etc.) the water enters an inlet tank (please refer to position 4 on the following diagram) via a solenoid
000254
1
valve (1). The inlet water tank (4) has a float valve (5) and an air gap to help isolate the flowpath from the municipal water system. The main pump (33) then creates a pressure of up to 20 bar that is required for the reverse osmosis process.
Pure water from the WRO unit is distributed directly to the distribution system in the hemodialysis unit via solenoid valves (48), (103), and (105). Excess pure water that has not been used in the hemodialysis unit is recirculated back to the inlet water tank (4) via solenoid valve (106).
In order to reduce water consumption, the speed of the pump is automatically adjusted so that the return flow of water is kept constant. Part of the reject water is recirculated back to the sucking side of the main pump via valve (71) to help minimize water consumption and to maintain a high flow velocity over the membrane surface. The rest of the reject water is, however, continuously sent to the drain via a needle valve (41).
The WRO unit utilizes a proportioning pump (45) and solution container (46) to proportion disinfectant during the disinfection cycle. The proportioning pump is disconnected from the flow path during normal operation.
The pure water line has a solenoid valve (36) for automatic flushing to drain at the start up, in conductivity alarm situations, every two hours, when the unit is in stand-by mode and at rinse during disinfection. The pure water line also has a solenoid valve arrangement to isolate the system from the distribution system during disinfection. The WRO unit has an overflow valve (64) on the pure water side to control pressure and to relieve pressure peaks.
Conductivity Monitoring
The conductivity of the inlet water and pure water are continuously monitored by two conductivity cells (32) and are presented on the display on the operator's panel.
Flow Monitoring
The following flow rates are monitored
| Flow | Sensor Position | Designation |
|---|---|---|
| Inlet Water | 3 | F1 |
| Reject From the RO Unit | 42 | F2 |
| Return Pure Water from | ||
| the Clinic | 51 | F4 |
These flow rates are used to calculate the following:
2
- Actual pure water consumption, . (F5=F1-F2)
- Outlet pure water flow, . (F6=F1-F2+F4)
All flow rates are presented on the operator's panel on request.
Heat Disinfection Unit
The heat disinfection unit consists of a tank (90) made of stainless steel and an electrical heater (91). The heater maintains the temperature of the pure water in the tank at either 60 ℃ (Low) or 90 ℃ (High). Heat disinfection of the pure water distribution system is initiated by the operator at the end of the dialysis day / session. A circulation pump (96) circulates hot water in the loop until the process is interrupted either manually by the operator, or at a preset time prior to the start of the next dialysis day / session. During the disinfection period, integrated heat disinfection with the dialysis machines can also be performed if the dialysis machines have a heat disinfection capability. The tank automatically refills with pure water from the WRO unit during the next operation. Heating of the water from 60 ℃ (Low) to 90 ℃ (High) takes approximately 2.5 hours if no circulation the loop takes place. During circulation periods the required time is longer because of heat losses and varies depending on the length and design of the system.
Heating Capacity
The heat disinfection unit is capable of maintaining 85 ℃ in a well insulated piping system with a maximum length of 150 meters.
3
p.4/5
Predicate Devices:
The Gambro Central Water Treatment System CWP 100 - WRO H is substantially equivalent to other water purification systems for hemodialysis in commercial distribution in the United States to include the Osmonics Osmo 23 G Series Reverse Osmosis Machines (FDA Document Control Number K931595 B. Both systems utilized reverse osmosis for purification of water to be used for hemodialysis. Both systems utilize a polyamide, thin film composite, spiral wound membrane for reverse osmosis. Both systems are intended to be used for water purification for hemodialysis. Both systems utilize substantially equivalent water contact materials for pumps, tubing, and other fittings, etc. Both systems utilize software for control and alarm systems. Both systems come in a number of sizes to accommodate varying product water output requirements. Both systems can utilize chemical disinfection using peracetic acid disinfection products. The Gambro water purification system has the additional advantage of having an integrated heat disinfection capability for both the reverse osmosis system and the distribution system.
We therefore consider the Gambro Central Water Treatment System CWP 100 - WRO H to be substantially equivalent to the Osmonics Osmo 23 G Series Reverse Osmos Machines. The following table provides the necessary information on the predicate device to which this system is substantially equivalent.
| DEVICE NAMES | Osmonics Osmo 23 G Series
Reverse Osmosis Machines |
|---------------|-------------------------------------------------------|
| INTENDED USE | Water Purification System for
Hemodialysis |
| 510K NUMBER | K 931595B |
| APPROVAL DATE | 1993 |
PREDICATE DEVICE
Intended Use:
The Gambro Central Water Treatment System CWP 100 - WRO H is designed to produce water of adquate quality for hemodialysis, both chemically and microbiologically with an adequate flow, provided that the feed water complies with the existing standards for drinking water and has been properly pre-treated.
This indication statement is essentially the same as the indication statement for the predicate device.
000257
4
Technological Characteristics:
Comparing the proposed device to the predicate device, some similarities and differences are noted in the design employed to accomplish the same intended use. Both systems utilized reverse osmosis for purification of water to be used for hemodialysis. Both systems utilize a polyamide, thin film composite, spiral wound membrane for reverse osmosis. Both systems are intended to be used for water purification for hemodialysis. Both systems utilize substantially equivalent water contact materials for pumps, tubing, and other fittings, etc. Both systems utilize software for control and alarm systems. Both systems come in a number of sizes to accommodate varying product water output Both systems can utilize chemical disinfection using peracetic acid requirements. disinfection products. The Gambro water purification system has the additional advantage of having an integrated heat disinfection capability for both the reverse osmosis system and the distribution system.
Summary of Non-Clinical Tests:
In vitro performance testing was performed on the Gambro Central Water Treatment Systems to establish normal operating performance to include flow rates, rejection of dissolved salts, organic materials, bacteria, and pyrogen. Additional testing was performed to evaluate the safety of the materials having water contact at various The results of these tests confirmed that the proposed device is temperatures. substantially equivalent to the proposed device for these parameters.
Clinical Test Results:
Clinical testing was not performed
Conclusions:
Testing performed on the Gambro Central Water Treatment System CWP 100 WRO H indicates that they are safe, effective, and perform as well as the predicate device, when used in accordance with the instructions for use.
5
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
Jeffrey R. Shideman, Ph.D. GAMBRO Healthcare 1185 Oak Street Lakewood, CO 80215-4498 Re: K974899 GAMBRO Reverse Osmosis System CWP 100-WRO-H Dated: July 7, 1998 Received: July 13, 1998 Regulatory Class: II 21 CFR 876.5665/Procode: 78 FIP
Dear Dr. Shideman:
SEP 2 3 1998
We have reviewed your Section 510(k) notification of intent to market the device referenced above and we have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class III (Premarket Approval), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21. Parts 800 to 895. A substantially equivalent determination assumes compliance with the Current Good Manufacturing Practice requirements, as set forth in the Quality System Regulation (OS) for Medical Devices: General regulation (21 CFR Part 820) and that, through periodic OS inspections, the Food and Drug Administration (FDA) will verify such assumptions. Failure to comply with the GMP regulation may result in regulatory action. In addition. FDA may publish further announcements concerning your device in the Federal Register. Please note: this response to your premarket notification submission does not affect any obligation you might have under sections 531 through 542 of the Act for devices under the Electronic Product Radiation Control provisions, or other Federal laws or regulations.
This letter will allow you to begin marketing your device as described in your 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801 and additionally 809.10 for in vitro diagnostic devices), please contact the Office of Compliance at (30) ) 594-4613. Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at (301) 594-4639. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR 807.97). Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its Internet address "http://www.fda.gov/cdrh/dsmadsmanan.html".
Sincerely yours.
Lillian Yin, Ph.D.
Director, Division of Reproducti Abdominal, Ear, Nose and Throat and Radiological Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
·
ure
6
Intended Use:
The Gambro Central Water Treatment System CWP 100 – WRO H is designed to produce
rally with and the first and can beth shorizedly and microhiologically with an The Gambro Central Water Treament System Chrysler who ir wobiologically with an
water of adquate quality for hemodialysis, both chemically and microsophyth water of adquate quality for nemodialysis, with the existing standards for daequale Jrow, pro has been properly pre-treated.
hollauhi
(Division Sign-Off) Division of Reproductive, Abdominal, ENT, and Radiological Devices 510(k) Number.
Prescription Use (Per 21 CFR 801.109)